Hospital

Black adults are suggested to have an increased risk of heart failure, which highlights the need for equitable treatment and decision-making.

The test has been available under emergency use authorization (EUA) since March of 2020 and was the first commercial molecular test to receive EUA status.

The approval includes a novel dose and schedule of the combination, with a single dose of both drugs followed by durvalumab every 4 weeks in patients with unresectable hepatocellular carcinoma.

Researchers conducted a review all 8 herpesviruses and their known treatments and found patients experienced encephalitis or another CNS symptom in almost every strain.

An ASCP 2022 session presenter explains some recent updates on vaccination guidance for the older adult population.

Researchers suggest that winter 2020 to 2021 public health interventions lowered natural immunity in children and put them at greater risk of respiratory infection after restrictions were lifted.

The treatment modulates the number of myosin heads that can enter “on actin” states and lowers the probability of force-producing (systolic) and residual (diastolic) cross-bridge formation.

Nivolumab may cut the risk of death or recurrent cancer by more than half, according to phase 3 trial results.

The risk of severe COVID-19 breakthrough infection was stronger with age and some comorbidities—the findings can inform antiviral distribution to prevent death or respiratory failure.

In a panel, pharmacy technicians across the world discuss how the role for pharmacy technicians will continue to grow post-pandemic in United States, Portugal, and the United Kingdom.

Tacrine was originally brought to the market in 1993 as an acetylcholinesterase inhibitor to fight the symptoms of Alzheimer disease.

A more comprehensive body of regulations is required to achieve consistency and safety for patients.

Sonidegib binds to and inhibits a transmembrane protein to disrupt hedgehog pathway signal transduction and leading to antitumor activity in patients with locally advanced basal cell carcinoma.

Deutetrabenazine is the only VMAT2 inhibitor approved by the FDA for the treatment of tardive dyskinesia in adults and for the treatment of chorea associated with Huntington disease.

Study finds daily supplementation with cod liver oil for 6 months during the SARS-CoV-2 pandemic did not reduce the incidence of SARS-CoV-2 infection.

In a panel, pharmacy technicians across the world discuss the differences of the role for pharmacy technicians in United States, Portugal, and the United Kingdom.

There is currently no approved RSV vaccine despite ongoing research efforts.

Improved workflow and optimal patient outcomes occur when technicians serve as vital members of the health care team, across the continuum of care.

Staying informed through the right sources and being mindful of antibiotic usage can help health care providers and patients be more prepared for future pandemics.

Rachel K. Anderson, PharmD, CSP, clinical program manager at Alliance Rx Walgreens Pharmacy, discusses the impact pharmacists have on the care journey for patients with multiple myeloma.

New research suggests that high levels of an immune protein in kidney disease might be able to predict risk of heart failure or death by reflecting the upstream process of stress.

Neutralizing antibodies increased by 34- to 27-fold compared to pre-booster levels when administered at 8 or 11 months post-primary series.

The TaqMan SARS-CoV-2, Flu A/B, RSV RT-PCR multiplex assay can differentiate between 3 different viral infections (including COVID-19), making it highly cost-effective.

Seventeen percent work in hospital settings, including compounding, inpatient, medication reconciliation, and outpatient areas.

In a panel, pharmacy technicians across the world discuss the qualifications and training pharmacy technicians need to have in the United States, Portugal, and the United Kingdom.

As part of American Pharmacist Month, Pharmacy Times is asking experts what they believe the value of the pharmacist is.

Immune function has been found to play a significant role in multiple myeloma.

Novavax’s quadrivalent influenza vaccine candidate has previously induced cross-reactive polyfunctional CD4+ T-cell responses, according to a company press release.